We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bioscience Vct | LSE:BVP | London | Ordinary Share | GB0031256109 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Shareholder Presentation
Seneca Growth Capital VCT Plc (the “Company”)
1 November 2022
Seneca Growth Capital VCT Plc
Shareholder update presentation
As previously communicated via the Company’s website, the next Investor Update Presentation will take place via Zoom, tomorrow 2 November 2022 at 11:00 AM.
The Directors of Seneca Growth Capital VCT Plc invite any shareholders not already registered to register for the presentation by following this link: https://us06web.zoom.us/webinar/register/WN_Jb9qP8fFRmydzu84gXOGIw
John Hustler (Chairman), Richard Manley (Seneca Partners CEO) and Matt Currie (Seneca Partners Investment Director) will provide a live presentation to update shareholders on the VCT and progress made with a Q&A session at the end to address questions.
We are inviting anyone with a question regarding the VCT to please get in touch with us via email. Please send your questions to enquiries@senecavct.co.uk and we will respond to those questions during the Q&A portion of the presentation. The Q&As and a recording of the presentation will also be published on the Company’s website following the presentation.
For further information, please contact:
Matt Currie, Seneca Partners Limited at Matt.Currie@senecapartners.co.uk
Siobhan Pycroft, Seneca Partners Limited at Siobhan.Pycroft@senecapartners.co.uk
1 Year Bioscience Vct Chart |
1 Month Bioscience Vct Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions